Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W J Huizinga

Showing results (141-150 of 207) with videos related to

Pageof 21
Sort By:
Annals of the Rheumatic Diseases|November 21, 2008
Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritisM M Thabet, T W J Huizinga, R B Marques, et al.
Scandinavian Journal of Rheumatology|November 23, 2011
Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progressionL Dirven, K Visser, N B Klarenbeek, et al.
Annals of the Rheumatic Diseases|April 28, 2016
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factorS Ajeganova, H W van Steenbergen, M K Verheul, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies presentV F A M Derksen, S Ajeganova, L A Trouw, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damageJ K de Vries-Bouwstra, Y P M Goekoop-Ruiterman, J Wesoly, et al.
Tissue Antigens|January 11, 2011
Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosisM Heron, C H M van Moorsel, J C Grutters, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 1, 2011
Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritisG Wheater, V E Hogan, Y K O Teng, et al.
Annals of the Rheumatic Diseases|May 26, 2010
A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt studyK Visser, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Annals of the Rheumatic Diseases|August 19, 2003
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisM Boers, M T Nurmohamed, C J A Doelman, et al.
Clinical Rheumatology|July 25, 2013
The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED studyL Heimans, K V C Wevers-de Boer, K Visser, et al.
Pageof 21

Showing results (141-150 of 207) with videos related to

Sort By:
Pageof 21
Annals of the Rheumatic Diseases|November 21, 2008
Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritisM M Thabet, T W J Huizinga, R B Marques, et al.
Scandinavian Journal of Rheumatology|November 23, 2011
Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progressionL Dirven, K Visser, N B Klarenbeek, et al.
Annals of the Rheumatic Diseases|April 28, 2016
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factorS Ajeganova, H W van Steenbergen, M K Verheul, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies presentV F A M Derksen, S Ajeganova, L A Trouw, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damageJ K de Vries-Bouwstra, Y P M Goekoop-Ruiterman, J Wesoly, et al.
Tissue Antigens|January 11, 2011
Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosisM Heron, C H M van Moorsel, J C Grutters, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 1, 2011
Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritisG Wheater, V E Hogan, Y K O Teng, et al.
Annals of the Rheumatic Diseases|May 26, 2010
A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt studyK Visser, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Annals of the Rheumatic Diseases|August 19, 2003
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisM Boers, M T Nurmohamed, C J A Doelman, et al.
Clinical Rheumatology|July 25, 2013
The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED studyL Heimans, K V C Wevers-de Boer, K Visser, et al.
Pageof 21